News
The purpose of this latest RFI is to increase the USCG’s understanding of the level of maturity of the U.S. and allied nation ...
AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback